Skip to search formSkip to main contentSkip to account menu

TAK 778

Known as: TAK-778 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Purpose:The aim of this study was to evaluate the in vivo effect of TAK-778 on osseointegration of titanium implants. Materials… 
2004
2004
TAK‐778, a derivative of ipriflavone, has been shown to induce bone growth in in vitro and in vivo models. However, there are no… 
2003
2003
TAK‐778 has been shown to induce bone growth in in vitro and in vivo models. However, there are no studies evaluating the effect… 
2002
2002
We investigated the application of alkylamines, as additives to the mobile phase, to a quantification method for the metabolites… 
2001
2001
We studied the stimulatory effects of TAK-778, a new synthetic 3-benzothiepin derivative that promotes osteoblast differentiation… 
2001
2001
The benzothiepin derivative (2R,4S)-(-)-N-(4-diethoxyphosphorylmethylphenyl)-1,2,4,5-tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo… 
2001
2001
We studied the stimulatory effects of TAK-778, a new synthetic 3-benzothiepin derivative that promotes osteoblast differentiation… 
2000
2000
The feasibility of using microcapsules containing a bone formation stimulant, (2R,4S)-(-)-N-(4-diethoxyphosphorylmethylphenyl)-1… 
1999
1999
TAK-778 [(2R,4S)-(-)-N-(4-diethoxyphosphorylmethylphenyl)-1,2,4, 5-tetrahydro-4-methyl-7, 8-methylenedioxy-5-oxo-3-benzothiepin-2… 
1999
1999
TAK-778, a novel synthetic 3-benzothiepin derivative, stimulates the formation of cartilaginous nodules in mouse…